Heavy Pharmaceutical Holdings (000950.SZ): Sales volume will exceed 100 billion yuan by 2025

Gelonghui Finance ·  Mar 14 19:15

Gelonghui, March 14 | Heavy Pharmaceutical Holdings (000950.SZ) said at an investor relations event that the company's overall strategic philosophy of the “14th Five-Year Plan” is “one thousand two, three hundred cities, three chemicals, four energy and five road forces”, that is, by 2025, the sales scale will exceed 100 billion yuan. Through “endogenous growth and epitaxial expansion” two-wheel drive, the layout will complete 300 prefecture-level markets across the country. Vigorously develop “batch and retail integration, product comprehensiveness, and business digitalization”, significantly enhance and cultivate the four service capabilities of “marketing business, supply chain, IT and auxiliary diagnosis and treatment”, and build five strategic forces of “device reagents, specialty pharmacies, traditional Chinese medicine health products, third-party storage and distribution, and emerging businesses” based on the core distribution business to promote the company's higher quality, steady and rapid development. In recent years, the company has been making steady progress around the 14th Five-Year Plan strategic goals and strives to fully complete the strategic goals by the end of the “14th Five-Year Plan”.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment